{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:24:48Z","timestamp":1787318688909,"version":"build-2736575974"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Anti-contactin-associated protein-like 2 (CASPR2) antibody-associated autoimmune encephalitis is commonly characterized by limbic encephalitis with clinical symptoms of mental and behavior disorders, cognitive impairment, deterioration of memory, and epilepsy. The classical lesions reported are located at the medial temporal lobe or hippocampus, whereas prominent brainstem lesions have not been addressed to date. Herein, we reported two patients mimicking progressive brainstem infarction with severe neurological manifestations. On brain magnetic resonance imaging (MRI), prominent brainstem lesions were noted, although multifocal lesions were also shown in the juxtacortical and subcortical white matters, basal ganglia, hippocampus, and cerebellar hemisphere. Unexpectedly and interestingly, both cases had detectable CASPR2 antibodies in sera, and an exclusive IgG1 subclass was documented in the further analysis. They were treated effectively with aggressive immunosuppressive therapies including corticosteroids, intravenous immunoglobulin G, and rituximab, with the first case achieving a rapid remission and the other undergoing a slow but gradual improvement. To the best of our knowledge, this is the first report on prominent brainstem involvement with definite MRI lesions in anti-CASPR2 antibody-associated autoimmune encephalitis, which helps to expand the clinical spectrum of this rare autoimmune disease and update the lesion patterns in the CNS.<\/jats:p>","DOI":"10.3389\/fimmu.2021.772763","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:30:58Z","timestamp":1636590658000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Case Report: Prominent Brainstem Involvement in Two Patients With Anti-CASPR2 Antibody-Associated Autoimmune Encephalitis"],"prefix":"10.3389","volume":"12","author":[{"given":"Pei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gejuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songdi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daidi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.84","article-title":"Autoantibodies in Chronic Inflammatory Neuropathies: Diagnostic and Therapeutic Implications","volume":"13","author":"Querol","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.14081","article-title":"Contactin-Associated Protein-Like 2, a Protein of the Neurexin Family Involved in Several Human Diseases","volume":"48","author":"Saint-Martin","year":"2018","journal-title":"Eur J Neurosci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-315720","article-title":"LGI1, CASPR2 and Related Antibodies: A Molecular Evolution of the Phenotypes","volume":"89","author":"Binks","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09686-2","article-title":"Systematic Review of the Clinical Spectrum of CASPR2 Antibody Syndrome","volume":"267","author":"Boyko","year":"2020","journal-title":"J Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-017-3222-0","article-title":"Expanding Spectrum of Contactin-Associated Protein 2 (CASPR2) Autoimmunity-Syndrome of Parkinsonism and Ataxia","volume":"39","author":"Kannoth","year":"2018","journal-title":"Neurol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301506","article-title":"Contactin-Associated Protein-2 Antibodies in Non-Paraneoplastic Cerebellar Ataxia","volume":"83","author":"Becker","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577515","article-title":"Anti-Contactin-Associated Protein-Like 2 Antibody-Associated Cerebellar Ataxia: A Case Report and Literature Review","volume":"353","author":"Wang","year":"2021","journal-title":"J Neuroimmunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12089","article-title":"Guillain-Barr\u00e9 Syndrome Associated With CASPR2 Antibodies: Two Paediatric Cases","volume":"19","author":"Rosch","year":"2014","journal-title":"J Peripher Nerv Syst"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182886991","article-title":"Autoimmune Chorea in Adults","volume":"80","author":"O\u2019Toole","year":"2013","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002917","article-title":"The Clinical Spectrum of Caspr2 Antibody-Associated Disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.4857","article-title":"Determination of Neuronal Antibodies in Suspected and Definite Creutzfeldt-Jakob Disease","volume":"71","author":"Grau-Rivera","year":"2014","journal-title":"JAMA Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000118","article-title":"A Case of Morvan Syndrome Mimicking Amyotrophic Lateral Sclerosis With Frontotemporal Dementia","volume":"17","author":"Freund","year":"2016","journal-title":"J Clin Neuromuscul Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002547","article-title":"Orthostatic Myoclonus Associated With Caspr2 Antibodies","volume":"86","author":"G\u00f6vert","year":"2016","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000366408","article-title":"Eyelid Tremor in a Patient With Anti-Caspr2 Antibody-Related Encephalitis","volume":"6","author":"Ueno","year":"2014","journal-title":"Case Rep Neurol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4103\/aian.AIAN_574_20","article-title":"Clinical Profile and Treatment Response in Patients With CASPR2 Antibody-Associated Neurological Disease","volume":"24","author":"Shivaram","year":"2021","journal-title":"Ann Indian Acad Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1212\/WNL.0000000000008015","article-title":"The Spectrum of Immune-Mediated and Inflammatory Lesions of the Brainstem: Clues to Diagnosis","volume":"93","author":"Law","year":"2019","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13180","article-title":"Anti-Contactin-Associated Protein-2 Encephalitis: Relevance of Antibody Titres, Presentation and Outcome","volume":"24","author":"Bien","year":"2017","journal-title":"Eur J Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652864","article-title":"Clinical Character of CASPR2 Autoimmune Encephalitis: A Multiple Center Retrospective Study","volume":"12","author":"Qin","year":"2021","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116865","article-title":"Expanding Clinical Spectrum of Caspr2 Antibody-Associated Disease: Warning on Brainstem Involvement and Respiratory Failure","volume":"413","author":"Di Giacomo","year":"2020","journal-title":"J Neurol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.1585","article-title":"Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-Like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures","volume":"73","author":"Joubert","year":"2016","journal-title":"JAMA Neurol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577393","article-title":"Anti-CASPR2 Antibody Associated Encephalitis With Anosmia and Demyelinating Pseudotumor: A Case Report","volume":"15","author":"Xing","year":"2020","journal-title":"J\u00a0Neuroimmunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/0004867418812687","article-title":"CASPR2 Encephalitis Presenting as Post-Partum Psychosis","volume":"53","author":"Warren","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jns.2014.03.043","article-title":"Caspr2 Antibody Limbic Encephalitis Is Associated With Hashimoto Thyroiditis and Thymoma","volume":"15","author":"Lee","year":"2014","journal-title":"J Neurol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ana.25120","article-title":"Mechanisms of Caspr2 Antibodies in Autoimmune Encephalitis and Neuromyotonia","volume":"83","author":"Patterson","year":"2018","journal-title":"Ann Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.772763\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:31:02Z","timestamp":1636590662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.772763\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":24,"alternative-id":["10.3389\/fimmu.2021.772763"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.772763","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"article-number":"772763"}}